drugset / Trial / NCT03631004

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

NCT03631004

Phase 2/3 Completed 100 enrolled Cancer Institute of the State of São Paulo
RandomizedParallel-groupTriple-blindPrevention

Summary

Olanzapine has been used as prophylactic antiemetic for chemotherapy induced nausea and vomiting. The project aims to evaluate the efficacy of olanzapine in combination with ondansetron and dexamethasone in patients at high risk of postoperative nausea and vomiting, with previous history of nausea and vomiting induced by prior chemotherapy, submitted to medium and large surgery.

Timeline

Start
2018-10-01
Primary completion
2021-02-10
Completion
2021-02-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 10 mg Oral

Indications

No indication recorded.